Israel Reports Highly-Effective COVID-19 Vaccine

According to local media reporting on January 28, 2021, the Comirnaty vaccine shows 92% effectiveness in Israel. Only 31 out of 163,000 Israelis vaccinated by Maccabi Healthcare Services caught coronavirus in their first 10 days of full-strength protection, its top vaccine statistics analyst, Anat Ekka Zohar, told The Times of Israel. In an equivalent sample of unvaccinated Israelis, some 6,437 were diagnosed in the same timeframe.

Additionally, the Israeli Ministry of Health's Director-General Prof. Chezy Levy issued guidance 'to lower the vaccinated population's age to 35 and older effective January 28, 2021.

Germany-based BioNTech and Pfizer co-developed the Comirnaty (BNT162b2) vaccine to prevent severe COVID-19. Comirnaty is a nucleoside-modified RNA formulated in lipid nanoparticles and encodes an optimized SARS-CoV-2 full-length spike protein antigen.